The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

Millions of people around the globe are impacted by migraines every day. This neurological issue commonly results in headaches. However, its implications extend beyond discomfort. Knowledge about the ...

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

Neurological disorders such as migraine and post-traumatic headache (PTH) not only cause significant individual suffering but also lead to substantial ...

The medication is not a replacement for CPAP therapy, which remains the first-line treatment for OSA. “This is the first drug treatment for obstructive sleep apnea, and so that’s exciting ...